These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21825240)

  • 21. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
    Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L; Yahr MD; Marinelli L; Huang N; Moshier E; Di Rocco A
    Parkinsonism Relat Disord; 2005 May; 11(3):151-5. PubMed ID: 15823479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
    Gour J; Edwards R; Lemieux S; Ghassemi M; Jog M; Duval C
    Brain Res Bull; 2007 Sep; 74(1-3):66-74. PubMed ID: 17683791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment.
    Prashanth LK; Fox S; Meissner WG
    Int Rev Neurobiol; 2011; 98():31-54. PubMed ID: 21907082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An automated methodology for levodopa-induced dyskinesia: assessment based on gyroscope and accelerometer signals.
    Tsipouras MG; Tzallas AT; Rigas G; Tsouli S; Fotiadis DI; Konitsiotis S
    Artif Intell Med; 2012 Jun; 55(2):127-35. PubMed ID: 22484102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation.
    Li MH; Mestre TA; Fox SH; Taati B
    J Neuroeng Rehabil; 2018 Nov; 15(1):97. PubMed ID: 30400914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset and spread of dyskinesias and motor symptoms in Parkinson's disease.
    Fabbrini G; Defazio G; Colosimo C; Suppa A; Bloise M; Berardelli A
    Mov Disord; 2009 Oct; 24(14):2091-6. PubMed ID: 19691126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study.
    Nimura T; Ando T; Yamaguchi K; Nakajima T; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2004 Apr; 100(4):606-10. PubMed ID: 15070112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F; Lilliu H; Le Pen C
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dyskinesia caused by L-DOPA].
    Derkinderen P; Vidailhet M
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia.
    Kleiner-Fisman G; Lozano A; Moro E; Poon YY; Lang AE
    Mov Disord; 2010 Jul; 25(10):1496-8. PubMed ID: 20568091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.
    Lee JY; Cho J; Lee EK; Park SS; Jeon BS
    Mov Disord; 2011 Jan; 26(1):73-9. PubMed ID: 20945430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR
    Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.
    Yoo HS; Chung SJ; Lee YH; Lee HS; Ye BS; Sohn YH; Lee PH
    Neurology; 2019 Mar; 92(13):e1468-e1478. PubMed ID: 30796137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology.
    Mera TO; Burack MA; Giuffrida JP
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():154-7. PubMed ID: 23365855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks.
    Keijsers NL; Horstink MW; Gielen SC
    Mov Disord; 2003 Jan; 18(1):70-80. PubMed ID: 12518302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Curr Neurol Neurosci Rep; 2007 Jul; 7(4):302-10. PubMed ID: 17618536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
    Strong JA; Dalvi A; Revilla FJ; Sahay A; Samaha FJ; Welge JA; Gong J; Gartner M; Yue X; Yu L
    Mov Disord; 2006 May; 21(5):654-9. PubMed ID: 16435402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyskinesia-induced postural instability in Parkinson's disease.
    Armand S; Landis T; Sztajzel R; Burkhard PR
    Parkinsonism Relat Disord; 2009 Jun; 15(5):359-64. PubMed ID: 18851925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.